Abstract
Patients with chronic daily headache have high frequencies of psychiatric comorbidity or psychologic distress in clinic-based studies. The presence of psychologic distress contributes to poor quality of life in patients with chronic daily headache. Antidepressants are effective in the treatment of chronic daily headache and its comorbid depression symptoms, although there is a discrepancy in the treatment response between chronic daily headache and comorbid depression. Comorbid major depression was a poor outcome predictor for chronic daily headache in clinic-based studies; however, the presence of psychologic distress did not predict the prognosis in population-based studies.A systematic investigation of psychiatric comorbidity is emphasized in patients with chronic daily headache and aims at a more comprehensive clinical management. Large-scale, longitudinal surveys and clinical trials specifically for psychiatric comorbidity of chronic daily headache are warranted to answer whether a syndromic relationship exists between different chronic daily headache subtypes and different psychiatric disorders, and to provide evidence-based treatment options for this large group of patients.
Similar content being viewed by others
References and Recommended Reading
Merikangas KR, Angst J, Isler H: Migraine and psychopathology. Arch Gen Psychiatry 1990, 47:849–853.
Merikangas KR, Merikangas JR, Angst J: Headache syndromes and psychiatric disorders: association and familiar transmission. J Psychiatr Res 1993, 27:197–210.
Breslau N, Davis GC, Schultz LR, Peterson EL: Migraine and major depression: a longitudinal study. Headache 1994, 34:387–393.
Breslau N, Schultz LR, Stewart WF, et al.: Headache and major depression: is the association specific to migraine? Neurology 2000, 54:308–313.
Stewart WF, Liner MS, Celentano DD: Migraine headaches and panic attacks. Psychosom Med 1989, 51:559–569.
Silberstein SD, Lipton RB, Bresalu N: Migraine: association with personality characteristics and psychopathology. Cephalalgia 1995, 15:358–369.
Scher AI, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.
Castillo J, Muñoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196.
Lu SR, Fuh JL, Chen WT, et al.: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up, and outcome predictors. Cephalalgia 2001, 21:980–986.
Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000, 54:314–319.
Monzon MJ, Lainez MJA: Quality of life in migraine and chronic daily headache patients. Cephalalgia 1998, 18:638–643.
Wang SJ, Fuh JL, Lu SR, Juang KD: Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 2001, 89:285–292. vides evidence of comorbid psychologic distress contributing to health-related quality of life in patients with chronic daily headache
Guitera V, Munoz P, Castillo J, Pascual J: Quality of life in chronic daily headache: a study in a general population. Neurology 2002, 58:1062–1065.
Holroyd KA, Stensland M, Lipchik GL, et al.: Psychosocial correlates and impact of chronic tension-type headache. Headache 2000, 40:3–16. omprehensive study investigating the psychiatric comorbidity and health-related quality of life in 245 patients with chronic tensiontype headache.
Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(suppl 7):1–96.
Olesen J, Rasmussen BK: The International Headache Society classification of chronic daily and near-daily headaches: a critique of the criticism. Cephalalgia 1996, 16:401–477.
Silberstein SD, Lipton RB: Chronic daily headache, dincluding transformed migraine, chronic tension-type headache, and medication overuse. In Wolff’s Headache and Other Head Pain, edn 7. Edited by Silberstein SD, Lipton RB, Dalessio DJ. Oxford: Oxford University Press; 2001:247–282.
Silberstein SD: Tension-type and chronic daily headache. Neurology 1993, 43:1644–1649.
Silberstein SD, Lipton RB, Solomon S, Mathew NT: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994, 34:1–7.
Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871–875.
Mathew NT, Stubits E, Nigam MP: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22:66–68.
Juang KD, Wang SJ, Fuh JL, et al.: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000, 40:818–823. A clinic-based study investigating the relationship among comorbid psychiatric disorders, gender, and subtypes of chronic daily headache.
Verri AP, Cecchini AP, Galli C, et al.: Psychiatric comorbidity in chronic daily headache. Cephalalgia 1998, 18(suppl 21):45–49.
Holden EW, Gladstein J, Trulsen M, Wall B: Chronic daily headache in children and adolescents. Headache 1994, 34:508–514.
Puca F, Genco S, Prudenzano MP, et al.: Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. Cephalalgia 1999, 19:159–164.
Mitsikostas DD, Thomas AM: Comorbidity of headache and depressive disorders. Cephalalgia 1999, 19:211–217.
Curioso EP, Young WB, Shechter AL, Kaiser RS: Psychiatric comorbidity predicts outcome in chronic daily headache patients. Neurology 1999, 52:A471.
Mathew NT, Reuveni U, Perez F: Transformed or evolutive migraine. Headache 1987, 27:102–106.
Magni G: On the relationship between chronic pain and depression when there is no organic lesion. Pain 1987, 31:1–21.
Rethelyi JM, Berghammer R, Kopp MS: Comorbidity of pain-associated disability and depressive symptoms in connection with sociodemographic variables: results from a cross-sectional epidemiologic survey in Hungary. Pain 2001, 93:115–121.
Roy-Byrne PP, Stang P, Wittchen HU, et al.: Lifetime panicdepression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000, 176:229–235.
Stewart WF, Shechter A, Liberman J: Physician consultation for headache pain and history of panic: results from a population-based study. Am J Med 1992, 92:35S-40S.
Redillas C, Solomon S: Prophylactic pharmacologic treatment of chronic daily headache. Headache 2000, 40:83–102. An extensive review of the efficacy of the prophylactic treatments of chronic daily headache, including their relationship with depression symptoms.
Lance JW, Curran DA: Treatment of chronic tension headache. Lancet 1964, I:1236–1239.
Diamond S, Baltes BJ: Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971, 11:110–116.
Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285–290.
Gobel H, Hamouz V, Hansen C, et al.: Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994, 59:241–249.
Peroutka SJ: The pharmacology of current anti-migraine drugs. Headache 1990, 30(suppl 2):7–12.
Pfaffenrath V, Kiener HC, Isler H, et al.: Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-center, controlled study. Cephalalgia 1994, 14:149–155.
Bussone G, Sandrini G, Patruno G, et al.: Effectiveness of fluoxetine on pain and depression in chronic headache disorders. In Headache and Depression: Serotonin Pathways As a Common Clue. Edited by Nappi G. New York: Raven Press; 1991:265–272.
Saper JR, Silberstein SD, Lake III AE, Winters ME: Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994, 34:497–502.
Foster CA, Bafaloukos J: Paroxetine in the treatment of chronic daily headache. Headache 1994, 34:587–589.
Saper JR, Lake III AE, Tepper SJ: Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache 2001, 41:465–474.
Lake III AE: Behavioral and nonpharmacologic treatments of headache. Med Clin North Am 2001, 85:1055–1075.
Holroyd KA, Penzien DB: Psychosocial interventions in the management of recurrent headache disorders 1: overview and effectiveness. Behav Med 1994, 20:53–63.
Holroyd KA, O’Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized, controlled trial. JAMA 2001, 285:2208–2215.
Tobin DL, Holroyd KA, Baker A, et al.: Development and clinical trial of a minimal contact, cognitive-behavioral treatment for tension headache. Cogn Ther Res 1988, 12:325–339.
Lu SR, Fuh JL, Juang KD, Wang SJ: Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache 2000, 40:724–729.
Siniatchkin M, Riabus M, Hasenbring M: Coping styles of headache sufferers. Cephalalgia 1999, 19:165–173.
Post RM, Silberstein SD: Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 1994, 44(suppl 7):S37-S47.
Srikiatkhachorn A, Govitrapong P, Kimthavon C: Up-regulation of 5-HT2 receptor: a possible mechanism of transformed migraine. Headache 1994, 34:8–11.
Srikiatkhachorn A, Maneesri S, Govitrapong P, Kasantikul V: Derangement of serotonin system in migrainous patients with analgesic abuse headache: clues from platelets. Headache 1998, 38:43–49.
Holm JE, Penzien DB, Holroyd KA, Brown TA: Headache and depression: confounding effects of transdiagnostic symptoms. Headache 1994, 34:418–423.
Kasper S, el Giamal N, Hilger E: Reboxetine: the first selective noradrenaline reuptake inhibitor. Exp Opin Pharmacother 2000, 1:771–782.
Golden RN, Rudorfer MV, Sherer MA, et al.: Bupropion in depression, I: biochemical effects and clinical response. Arch Gen Psychiatry 1988, 45:139–143.
Silverstone PH, Salinas E: Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. J Clin Psychiatry 2001, 62:523–529.
Pollack MH, Zaninelli R, Goddard A, et al.: Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001, 62:350–357.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, SJ., Juang, KD. Psychiatric comorbidity of chronic daily headache: Impact, treatment, outcome, and future studies. Current Science Inc 6, 505–510 (2002). https://doi.org/10.1007/s11916-002-0071-0
Issue Date:
DOI: https://doi.org/10.1007/s11916-002-0071-0